HISTIOCYTIC SARCOMA
Clinical trials for HISTIOCYTIC SARCOMA explained in plain language.
Never miss a new study
Get alerted when new HISTIOCYTIC SARCOMA trials appear
Sign up with your email to follow new studies for HISTIOCYTIC SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug Q702 aims to boost immune system against blood cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called Q702 in people with certain blood cancers or related diseases that have not responded to other treatments. The drug works by helping the immune system attack cancer cells and supporting normal blood cell production. The study will ch…
Matched conditions: HISTIOCYTIC SARCOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 04:09 UTC
-
New drug targets rare immune diseases that resist standard care
Disease control Recruiting nowThis study tests a drug called cobimetinib in children and adults with histiocytic disorders that have come back or not responded to other treatments. Cobimetinib blocks a faulty growth signal inside cells. The goal is to see if the drug can shrink tumors and slow the disease. Ab…
Matched conditions: HISTIOCYTIC SARCOMA
Phase: PHASE2 • Sponsor: Carl Allen • Aim: Disease control
Last updated May 14, 2026 12:02 UTC